Tradestie Institutional Equity Comparison Engine

BMY vs CMCSA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BMY Overall Edge

BMY Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Bristol-Myers Squibb Co. (BMY) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while CMCSA counters with relative strength in Valuation. Fundamentally, BMY trades at 8.8x Forward P/E with 32.4% operating margin (+6.9% YoY revenue) versus CMCSA at 7.1x Forward P/E and 14.7% operating margin (-6.1% YoY). In options structure, BMY sits in CONSOLIDATION (24th %ile IV; Dealer Gamma Walls on Pro) against CMCSA sits in CONSOLIDATION (30th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CMCSA
BMY 8.8x vs CMCSA 7.1x Fwd P/E
Growth & Margin Winner BMY
Op Margin 32.4% vs 14.7% ยท YoY +6.9% vs -6.1%
Momentum & Technical Winner BMY
1Y +28.4% vs -7.3% ยท 52W Pos 58% vs 36%
Options & Structure Winner BMY
CONSOLIDATION (24th %ile IV) vs CONSOLIDATION (30th %ile IV)
BMY NYSE
Bristol-Myers Squibb Co.
Pharmaceutical Preparations
$58.80
+0.79% 1D
Market Cap $119.3B
1M Return -6.67%
1Y Return +28.41%
Forward P/E 8.8x
Unified AI Score
48.9 / 100 HOLD
Tech 44.0 Fund 53.0 Flow 70.0 Mom 46.0
CMCSA NASDAQ
Comcast Corp
Cable & Other Pay Television Services
$24.90
+0.16% 1D
Market Cap $88.3B
1M Return +9.02%
1Y Return -7.33%
Forward P/E 7.1x
Unified AI Score
32.8 / 100 SELL
Tech 20.0 Fund 44.0 Flow 59.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BMY +28.41% CMCSA -7.33% Spread: +35.74 pp (BMY Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BMY Revenue CMCSA Revenue BMY Op. Margin CMCSA Op. Margin Margin Edge
FY2018 $22.6B $94.5B 21.8% 20.1% BMY
FY2019 $26.1B $108.9B 13.2% 19.4% CMCSA
FY2020 $42.5B $103.6B -21.2% 16.9% CMCSA
FY2021 $46.4B $116.4B 15.1% 17.9% CMCSA
FY2022 $46.2B $121.4B 13.7% 11.6% BMY
FY2023 $45.0B $121.6B 17.8% 19.2% CMCSA
FY2024 $48.3B $123.7B -18.5% 18.8% CMCSA
FY2025 $48.2B $123.7B 14.6% 16.7% CMCSA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BMY (8) vs CMCSA (2)
Institutional Metric BMY CMCSA Criterion Row Winner
Market Capitalization Scale $119.3B $88.3B Larger Scale BMY
Trailing P/E Ratio Valuation 12.9x 7.9x Lower Multiple CMCSA
Forward P/E Ratio Valuation 8.8x 7.1x Lower Multiple CMCSA
Revenue Growth (YoY) Growth +6.9% -6.1% Higher Growth BMY
Operating Margin (TTM) Profitability 32.4% 14.7% Higher Margin BMY
Net Profit Margin Profitability 18.5% 9.2% Higher Margin BMY
Return on Equity (ROE) Capital Efficiency 44.0% 11.4% Higher ROE BMY
52-Week Range Position Momentum 58% ($45โ€“$69) 36% ($20โ€“$33) Stronger Trend BMY
Beta / 30D Volatility Risk Regime 0.16ฮฒ ยท 28% Vol -0.01ฮฒ ยท 32% Vol Lower Realized Risk BMY
Unified Institutional Score Composite Signal 48.9 / 100 (HOLD) 32.8 / 100 (SELL) Higher Composite BMY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BMY vs CMCSA Buy Guide
BMY CONSOLIDATION
55d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 24th %ile
IV Regime Compressed (<25th %ile)
Live BMY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CMCSA CONSOLIDATION
61d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 30th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CMCSA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BMY nor CMCSA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.